A detailed history of Merriman Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Merriman Wealth Management, LLC holds 2,373 shares of NVO stock, worth $249,805. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,373
Previous 2,325 2.06%
Holding current value
$249,805
Previous $331,000 14.8%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $5,715 - $6,980
48 Added 2.06%
2,373 $282,000
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $17,792 - $21,301
145 Added 6.65%
2,325 $331,000
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $19,298 - $25,688
189 Added 9.49%
2,180 $279,000
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $174,769 - $209,950
1,991 New
1,991 $205,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Merriman Wealth Management, LLC Portfolio

Follow Merriman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merriman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merriman Wealth Management, LLC with notifications on news.